JP2014503566A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503566A5
JP2014503566A5 JP2013550832A JP2013550832A JP2014503566A5 JP 2014503566 A5 JP2014503566 A5 JP 2014503566A5 JP 2013550832 A JP2013550832 A JP 2013550832A JP 2013550832 A JP2013550832 A JP 2013550832A JP 2014503566 A5 JP2014503566 A5 JP 2014503566A5
Authority
JP
Japan
Prior art keywords
cyclohepta
pyrimidine
amino
tetrahydropyrazolo
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013550832A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503566A (ja
JP5925808B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/050765 external-priority patent/WO2012101029A1/en
Publication of JP2014503566A publication Critical patent/JP2014503566A/ja
Publication of JP2014503566A5 publication Critical patent/JP2014503566A5/ja
Application granted granted Critical
Publication of JP5925808B2 publication Critical patent/JP5925808B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013550832A 2011-01-26 2012-01-19 三環式誘導体、これらの調製方法およびこれらのキナーゼ阻害剤としての使用 Expired - Fee Related JP5925808B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11152189.4 2011-01-26
EP11152189 2011-01-26
PCT/EP2012/050765 WO2012101029A1 (en) 2011-01-26 2012-01-19 Tricyclic derivatives, process for their preparation and their use as kinase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015203444A Division JP2016053043A (ja) 2011-01-26 2015-10-15 三環式誘導体、これらの調製方法およびこれらのキナーゼ阻害剤としての使用

Publications (3)

Publication Number Publication Date
JP2014503566A JP2014503566A (ja) 2014-02-13
JP2014503566A5 true JP2014503566A5 (enExample) 2015-03-05
JP5925808B2 JP5925808B2 (ja) 2016-05-25

Family

ID=45507697

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013550832A Expired - Fee Related JP5925808B2 (ja) 2011-01-26 2012-01-19 三環式誘導体、これらの調製方法およびこれらのキナーゼ阻害剤としての使用
JP2015203444A Withdrawn JP2016053043A (ja) 2011-01-26 2015-10-15 三環式誘導体、これらの調製方法およびこれらのキナーゼ阻害剤としての使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015203444A Withdrawn JP2016053043A (ja) 2011-01-26 2015-10-15 三環式誘導体、これらの調製方法およびこれらのキナーゼ阻害剤としての使用

Country Status (5)

Country Link
US (1) US8916577B2 (enExample)
EP (1) EP2668188B1 (enExample)
JP (2) JP5925808B2 (enExample)
ES (1) ES2586588T3 (enExample)
WO (1) WO2012101029A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR077468A1 (es) 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
JP5046404B2 (ja) 2009-09-25 2012-10-10 信越化学工業株式会社 ω末端にポリアルキレンオキシド基を有する片末端反応性オルガノポリシロキサン及びその製造方法。
JP6437452B2 (ja) 2013-01-14 2018-12-12 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Pimキナーゼ阻害剤として有用な二環式芳香族カルボキサミド化合物
LT2945939T (lt) 2013-01-15 2020-07-27 Incyte Holdings Corporation Triazolkarboksamidai ir piridinkarboksamido junginiai, naudotini kaip pim kinazės inhibitoriai
EP3036238A1 (en) 2013-08-23 2016-06-29 Incyte Corporation Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors
US9580418B2 (en) 2014-07-14 2017-02-28 Incyte Corporation Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors
US9822124B2 (en) 2014-07-14 2017-11-21 Incyte Corporation Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors
CN105085489B (zh) 2014-11-05 2019-03-01 益方生物科技(上海)有限公司 嘧啶或吡啶类化合物、其制备方法和医药用途
CA2981844A1 (en) 2015-04-17 2016-10-20 Netherlands Translational Research Center B.V. Prognostic biomarkers for ttk inhibitor chemotherapy
US9540347B2 (en) 2015-05-29 2017-01-10 Incyte Corporation Pyridineamine compounds useful as Pim kinase inhibitors
DK3322706T3 (da) 2015-07-16 2021-02-01 Array Biopharma Inc Substituerede pyrazolo[1,5-a]pyridin-forbindelser som ret-kinaseinhibitorer
DK3341376T3 (da) * 2015-08-26 2021-03-29 Fundacion Del Sector Publico Estatal Centro Nac De Investigaciones Oncologicas Carlos Iii F S P Cnio Kondenserede tricykliske forbindelser som proteinkinase-inhibitorer
AR105967A1 (es) 2015-09-09 2017-11-29 Incyte Corp Sales de un inhibidor de pim quinasa
WO2017059251A1 (en) 2015-10-02 2017-04-06 Incyte Corporation Heterocyclic compounds useful as pim kinase inhibitors
JP2018534296A (ja) 2015-10-26 2018-11-22 ロクソ オンコロジー, インコーポレイテッドLoxo Oncology, Inc. Trk阻害薬耐性がんにおける点変異およびそれに関連する方法
RS65988B1 (sr) 2016-04-04 2024-10-31 Loxo Oncology Inc Postupak lečenja pedijatrijskih karcinoma
US10045991B2 (en) 2016-04-04 2018-08-14 Loxo Oncology, Inc. Methods of treating pediatric cancers
MX386416B (es) 2016-04-04 2025-03-18 Loxo Oncology Inc Formulaciones liquidas de (s)-n-(5-((r)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida.
HUE063877T2 (hu) 2016-05-18 2024-02-28 Loxo Oncology Inc (S)-N-(5-((R)-2-(2,5-dlfluorofenil)pirolidin-1-il)plrazolo[1,5-A]pirimidin-3-il) -3-hidroxipirolidin-1-karboxamid elõállítása
TWI704148B (zh) 2016-10-10 2020-09-11 美商亞雷生物製藥股份有限公司 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
JOP20190077A1 (ar) 2016-10-10 2019-04-09 Array Biopharma Inc مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
JOP20190092A1 (ar) 2016-10-26 2019-04-25 Array Biopharma Inc عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
CA3049136C (en) 2017-01-18 2022-06-14 Array Biopharma Inc. Substituted pyrazolo[1,5-a]pyrazine compounds as ret kinase inhibitors
WO2018136663A1 (en) 2017-01-18 2018-07-26 Array Biopharma, Inc. Ret inhibitors
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
CN107383019B (zh) * 2017-07-28 2019-10-15 江苏艾凡生物医药有限公司 吡唑并[4,3-h]喹唑啉类化合物及其用途
TWI791053B (zh) 2017-10-10 2023-02-01 美商亞雷生物製藥股份有限公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
TWI812649B (zh) 2017-10-10 2023-08-21 美商絡速藥業公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
TW201924683A (zh) 2017-12-08 2019-07-01 美商英塞特公司 用於治療骨髓增生性贅瘤的低劑量組合療法
CA3087578C (en) 2018-01-18 2023-08-08 Array Biopharma Inc. Substituted pyrazolo[3,4-d]pyrimidine compounds as ret kinase inhibitors
WO2019143994A1 (en) 2018-01-18 2019-07-25 Array Biopharma Inc. Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors
CA3087354C (en) 2018-01-18 2023-01-03 Array Biopharma Inc. Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors
KR102545594B1 (ko) 2018-07-31 2023-06-21 록쏘 온콜로지, 인코포레이티드 (s)-5-아미노-3-(4-((5-플루오로-2-메톡시벤즈아미도)메틸)페닐)-1-(1,1,1-트리플루오로프로판-2-일)-1h-피라졸-4-카르복스아미드의 분무-건조된 분산물 및 제제
CN112996794A (zh) 2018-09-10 2021-06-18 阿雷生物药品公司 作为ret激酶抑制剂的稠合杂环化合物
EP3898626A1 (en) 2018-12-19 2021-10-27 Array Biopharma, Inc. Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases
JP2022515197A (ja) 2018-12-19 2022-02-17 アレイ バイオファーマ インコーポレイテッド がんを治療するためのfgfr阻害剤としての7-((3,5-ジメトキシフェニル)アミノ)キノキサリン誘導体
WO2021113492A1 (en) 2019-12-06 2021-06-10 Schrödinger, Inc. Cyclic compounds and methods of using same
WO2021134004A1 (en) 2019-12-27 2021-07-01 Schrodinger, Inc. Cyclic compounds and methods of using same
JP2023541047A (ja) 2020-09-10 2023-09-27 シュレーディンガー, インコーポレイテッド がんの治療のための複素環式ペリ縮環cdc7キナーゼ阻害剤
CN114685520B (zh) * 2020-12-25 2024-08-30 武汉誉祥医药科技有限公司 三并环化合物及其药物组合物和应用
US20240148732A1 (en) 2021-01-26 2024-05-09 Schrödinger, Inc. Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disorders
TW202300150A (zh) 2021-03-18 2023-01-01 美商薛定諤公司 環狀化合物及其使用方法
WO2025059027A1 (en) 2023-09-11 2025-03-20 Schrödinger, Inc. Cyclopenta[e]pyrazolo[1,5-a]pyrimidine derivatives as malt1 inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008130A (es) * 2002-02-19 2004-11-26 Pharmacia Corp Derivados triciclicos de pirazol para el tratamiento de la inflamacion.
RS20050944A (sr) * 2003-05-22 2008-06-05 Nerviano Medical Sciences S.R.L., Derivati pirazolo- hinazolina,postupci za njihovo dobijanje i njihova upotreba kao inhibitora kinaze
CN1897950A (zh) 2003-10-14 2007-01-17 惠氏公司 稠合芳基和杂芳基衍生物及其使用方法
WO2008065054A1 (en) * 2006-11-28 2008-06-05 Nerviano Medical Sciences S.R.L. Tricyclic indoles and (4,5-dihydro) indoles
SI2125822T1 (sl) * 2006-12-21 2015-01-30 Nerviano Medical Sciences S.R.L. Substituirani pirazolo-kinazolinski derivati, postopek za njihovo pripravo in njihova uporaba kot inhibitorji kinaze
CN101687869A (zh) * 2007-07-16 2010-03-31 诺瓦提斯公司 作为mk2抑制剂的四环内酰胺衍生物
JP2011509261A (ja) 2008-01-07 2011-03-24 シンタ ファーマシューティカルズ コーポレーション 炎症および免疫関連用途向けの化合物
WO2009137492A1 (en) * 2008-05-05 2009-11-12 Abbott Laboratories Heteroaryl-fused macrocyclic pyrimidine derivatives
WO2009156315A1 (en) 2008-06-26 2009-12-30 Nerviano Medical Sciences S.R.L. Pyrazolo-quinazolines
US8946226B2 (en) * 2008-07-29 2015-02-03 Nerviano Medical Sciences S.R.L. Use of CDK inhibitor for the treatment of glioma
CN102105152B (zh) * 2008-07-29 2012-10-17 内尔维阿诺医学科学有限公司 包含cdks抑制剂和抗肿瘤剂的治疗组合
US8912194B2 (en) * 2008-11-24 2014-12-16 Nerviano Medical Sciences S.R.L. CDK inhibitor for the treatment of mesothelioma
JP5650193B2 (ja) * 2009-03-20 2015-01-07 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ 胸腺腫の治療のためのキナーゼ阻害剤の使用
ES2660146T3 (es) * 2009-04-29 2018-03-21 Nerviano Medical Sciences S.R.L. Sales del inhibidor de cdk
AR076784A1 (es) * 2009-05-26 2011-07-06 Nerviano Medical Sciences Srl Combinacion terapeutica que comprende un inhibidor de plk1 y un agente antineoplasico
CN103626777B (zh) * 2009-07-29 2015-10-21 内尔维阿诺医学科学有限公司 Plk抑制剂的盐类
JP5997143B2 (ja) * 2010-07-30 2016-09-28 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ タンパク質キナーゼ活性の調整剤としてのイソオキサゾロ−キナゾリン
CA2812223C (en) * 2010-12-17 2019-03-12 Nerviano Medical Sciences S.R.L. Substituted pyrazolo-quinazoline derivatives as kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2014503566A5 (enExample)
ES2872555T3 (es) Inhibidores de HPK1 y métodos de uso de los mismos
AU2015276537B2 (en) Novel compounds as dual inhibitors of histone methyltransferases and dna methyltransferases
ES2968252T3 (es) Compuesto 8,9-dihidroimidazol[1,2-a]pirimido[5,4-e]pirimidin-5(6H)-cetona
US8987280B2 (en) Pyrazolopyrimidine PI3K inhibitor compounds and methods of use
JP5925808B2 (ja) 三環式誘導体、これらの調製方法およびこれらのキナーゼ阻害剤としての使用
ES2415863T3 (es) Heterociclos sustituidos como inhibidores de Janus Quinasas
JP5997763B2 (ja) タンパク質キナーゼ阻害剤としての大環状化合物
JP2016053042A5 (enExample)
JP2014503567A5 (enExample)
AU2020286339B2 (en) Compositions and methods for inhibiting kinases
JP2020503299A5 (enExample)
RU2013139353A (ru) Трициклические пирролопроизводные, способ их получения и их применение в качестве ингибиторов киназы
BR112020008836A2 (pt) Moduladores da via de estresse integrada
BR112013026137B1 (pt) pirimidinil-pirróis substituídos ativos como inibidores da quinase
SG194397A1 (en) Pyrazolopyrimidine jak inhibitor compounds and methods
TR201808599T4 (tr) Histon demetilaz inhibitörleri.
JP2014528433A5 (enExample)
KR20120062839A (ko) 단백질 키나제 억제제로서의 화합물 및 조성물
EA017952B1 (ru) ПИРРОЛО[2,3-d]ПИРИДИНЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ТИРОЗИНКИНАЗЫ
CN100591355C (zh) 治疗过度增殖疾病的组合物及其制药用途
US20130065883A1 (en) Triazolo [4, 5- B] Pyridin Derivatives
BR112020006169A2 (pt) inibidores de quinase p38 que reduzem dux4 e expressão de gene a jusante para o tratamento de fshd
KR20140022057A (ko) Akt 키나제 억제제로서의 이미다조피리다진
JP2016525104A5 (enExample)